Pharmacogenetics of anticancer agents : UGT1A1 polymorphism and irinotecan toxicity
スポンサーリンク
概要
- 論文の詳細を見る
- 2005-01-01
著者
-
Ando Yuichi
Department Of Clinical Oncology Saitama Medical School
-
Ando Yuichi
Department Of Clinical Oncology And Chemotherapy Nagoya University Hospital
関連論文
- The Synergistic Effect of Bactobolamine and Tacrolimus on In Vitro and In Vivo Experiments
- A Nonspecific Colonic Ulcer Occurring After Hepatectomy: Report of a Case
- Association of ATP-Binding Cassette, Sub-family C, Number 2 (ABCC2) Genotype with Pharmacokinetics of Irinotecan in Japanese Patients with Metastatic Colorectal Cancer Treated with Irinotecan Plus Infusional 5-Fluorouracil/Leucovorin (FOLFIRI)(Miscellaneo
- CYP2A6 and the plasma level of 5-chloro-2,4-dihydroxypyridine are determinants of the pharmacokinetic variability of tegafur and 5-fluorouracil, respectively, in Japanese patients with cancer given S-1
- Mortality rates of community-residing adults with and without dentures
- Pharmacogenetic impact of polymorphisms in the coding region of the UGT1A1 gene on SN-38 glucuronidation in Japanese patients with cancer
- Novel Single Nucleotide Polymorphism of UGT1A9 Gene in Japanese
- Novel Single Nucleotide Polymorphism of UGT1A7 Gene in Japanese
- Effect of Imatinib (STI571) on Metastatic Gastrointestinal Stromal Tumors : Report of a Case
- Associations between functional tooth number and physical complaints of community-residing adults in a 15-year cohort study
- Acute gefitinib-induced pneumonitis
- Prospective evaluation of pharmacokinetically guided dosing of carboplatin in Japanese patients with cancer
- Pharmacogenetics of anticancer agents : UGT1A1 polymorphism and irinotecan toxicity